Views & Analysis Women in Science: AstraZeneca We speak to three of AstraZeneca’s senior leaders about their careers, the future of their therapy areas and how the industry can encourage and support more women to purs
News Taiho's late-stage Duchenne candidate fails trial Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face